通过人工智能进行心脏流量测试, 可以与治疗指导的侵入性方法相匹配. AI heart flow tests match invasive methods for guiding treatment.

最近在2026年美国心脏病学会科学会议上发表的两项研究发现,使用人工智能和血管造影测量心脏血流量的非侵入性技术与传统的入侵方法一样有效. Two recent studies presented at the 2026 American College of Cardiology Scientific Sessions found that non-invasive technologies using artificial intelligence and angiography to measure blood flow in the heart are as effective as traditional invasive methods for guiding treatment. 对于主要临床事件如心脏病发作和死亡,ALL- RISE 和 FAST- III 的试验显示不劣的结果. The trials, ALL-RISE and FAST-III, showed non-inferior results regarding major clinical events like heart attacks and death. 另外,非侵入性选择减少了手术时间,辐射暴露和对比染料的使用. Additionally, the non-invasive options reduced procedure time, radiation exposure, and the need for contrast dye.